BioNTech US, Inc.. (NTGN) NASDAQ

$3.07 - (-)

Market Cap: $88.92M

As of 05/05/20 12:00 AM EDT. Market closed.

(NTGN)

BioNTech US, Inc.. (NTGN)
NASDAQ

$3.07
- (-)

Market Cap: $88.92M

As of 05/05/20 12:00 AM EDT. Market closed.

Add to Portfolio

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, ... read more

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO Compensation (Base)
$475,000
CEO Compensation (Total)
$2.40M
URL
Address
40 Erie Street, MA, Cambridge, 02139.
Sector
Health Technology
Industry
Biotechnology
Full Time Employees
71
CEO Compensation (Base)
$475,000
CEO Compensation (Total)
$2.40M
Address
40 Erie Street, MA, Cambridge, 02139.
PRICE CHART FOR BIONTECH US, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$3.07
Days Range
- - -
52 week range
$0.88 - $6.15
Volume
0
Avg. Volume (30 days)
514,779
Market Cap
$88.92M
Dividend Yield
-
P/E
-
Shares Outstanding
28,963,858
Open
-
Previous Close
$3.07
Days Range
- - -
52 week range
$0.88 - $6.15
Volume
0
Avg. Volume (30 days)
514,779
Market Cap
$88.92M
Dividend Yield
-
P/E
-
Shares Outstanding
28,963,858
FINANCIAL STATEMENTS FOR BIONTECH US, INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIONTECH US, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Access Industries Holdings LLC10% OwnerMar 23, 2020 Sale$2.1750,358109,483940,590Mar 25, 2020, 05:28 PM
Access Industries Holdings LLC10% OwnerMar 24, 2020 Sale$2.1984,286184,780856,304Mar 25, 2020, 05:28 PM
Access Industries Holdings LLC10% OwnerMar 24, 2020 Sale$2.20117,400258,5381,896,176Mar 25, 2020, 05:28 PM
Access Industries Holdings LLC10% OwnerMar 20, 2020 Sale$2.2284,339186,9042,013,576Mar 23, 2020, 09:00 PM
Access Industries Holdings LLC10% OwnerMar 19, 2020 Sale$2.519,05022,760990,948Mar 23, 2020, 09:00 PM
Siegel JolieVP, General CounselFeb 29, 2020 Option Exercise$1.502,8454,268161,821Mar 02, 2020, 06:39 PM
GAYNOR RICHARDPresident of R&DFeb 29, 2020 Option Exercise$1.505,6258,438210,410Mar 02, 2020, 06:39 PM
Al-Wakeel Yasir B.Chief Financial OfficerFeb 29, 2020 Option Exercise$1.504,8917,337196,965Mar 02, 2020, 06:39 PM
O'Dowd HughPresident & CEOFeb 29, 2020 Option Exercise$1.509,78314,675776,085Mar 02, 2020, 06:38 PM
Al-Wakeel Yasir B.Chief Financial OfficerFeb 25, 2020 Option Exercise$1.515,3858,131201,856Feb 27, 2020, 06:21 PM
Siegel JolieVP, General CounselFeb 25, 2020 Option Exercise$1.515,3348,054164,666Feb 27, 2020, 06:21 PM
GAYNOR RICHARDPresident of R&DFeb 25, 2020 Option Exercise$1.515,4658,252216,035Feb 27, 2020, 06:21 PM
GAYNOR RICHARDPresident of R&DNov 27, 2019 Sale$1.2422,32227,644156,500Nov 27, 2019, 05:01 PM
GAYNOR RICHARDPresident of R&DNov 26, 2019 Sale$1.3123,00030,231178,822Nov 27, 2019, 05:01 PM
GAYNOR RICHARDPresident of R&DNov 25, 2019 Sale$1.3720,00027,498201,822Nov 27, 2019, 05:01 PM
O'Dowd HughPresident & CEOAug 20, 2018 Option Exercise$2.6518,86850,000445,868Aug 22, 2018, 04:18 PM
Al-Wakeel Yasir B.Chief Financial OfficerJul 17, 2018 Option Exercise$5.8017,24199,99817,241Jul 18, 2018, 04:38 PM
Access Industries Holdings LLC10% OwnerJun 29, 2018 Buy$16.00315,0005,040,0002,097,915Jul 03, 2018, 02:10 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Access Industries Holdings LLC10% Owner03/23/2020109,483
Access Industries Holdings LLC10% Owner03/24/2020184,780
Access Industries Holdings LLC10% Owner03/24/2020258,538
Access Industries Holdings LLC10% Owner03/20/2020186,904
Access Industries Holdings LLC10% Owner03/19/202022,760
Siegel JolieVP, General Counsel02/29/20204,268
GAYNOR RICHARDPresident of R&D02/29/20208,438
Al-Wakeel Yasir B.Chief Financial Officer02/29/20207,337
O'Dowd HughPresident & CEO02/29/202014,675
Al-Wakeel Yasir B.Chief Financial Officer02/25/20208,131
Siegel JolieVP, General Counsel02/25/20208,054
GAYNOR RICHARDPresident of R&D02/25/20208,252
GAYNOR RICHARDPresident of R&D11/27/201927,644
GAYNOR RICHARDPresident of R&D11/26/201930,231
GAYNOR RICHARDPresident of R&D11/25/201927,498
O'Dowd HughPresident & CEO08/20/201850,000
Al-Wakeel Yasir B.Chief Financial Officer07/17/201899,998
Access Industries Holdings LLC10% Owner06/29/20185,040,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR BIONTECH US, INC.
LOADING...